NEW YORK (GenomeWeb) – NanoString Technologies said on Tuesday that it has signed a deal with investment bank Cowen and Company to sell up to $40 million of its common stock from time to time.

Under the agreement, Cowen may sell the shares through an "at-the-market" offering, in which shares are offered at the prevailing market rates. The firm may also sell the stock by other methods, including through privately negotiated deals.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.